Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination

By Habermehl P.   Lignitz A.   Knuf M.   Schmitt H.-J.   Slaoui M.   Zepp F.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 669-674

Elsevier

Access to resources Recommend Favorite

The cost-effectiveness of varicella vaccine programs for Australia

By Scuffham P.A.   Lowin A.V.   Burgess M.A.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 407-415

Elsevier

Access to resources Recommend Favorite

Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine

By Sato H.   Yamamura J.-i.   Kageyama S.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine

By Terada K.   Niizuma T.   Ogita S.   Kataoka N.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3638-3643

Elsevier

Access to resources Recommend Favorite

Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine

By Sato H.   Kageyama S.   Imakita M.   Ida M.   Yamamura J.-i.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1263-1269

Elsevier

Access to resources Recommend Favorite